BIOMAT Database Logo BIOMAT Database Logo

Immunochemical characterization on pathological oligomers of mutant Cu/Zn-superoxide dismutase in amyotrophic lateral sclerosis. 2017

Eiichi Tokuda, and Itsuki Anzai, and Takao Nomura, and Keisuke Toichi, and Masahiko Watanabe, and Shinji Ohara, and Seiji Watanabe, and Koji Yamanaka, and Yuta Morisaki, and Hidemi Misawa, and Yoshiaki Furukawa
Laboratory for Mechanistic Chemistry of Biomolecules, Department of Chemistry, Keio University, 3-14-1 Hiyoshi, Kohoku, Yokohama, Kanagawa, 223-8522, Japan.

Dominant mutations in Cu/Zn-superoxide dismutase (SOD1) gene cause a familial form of amyotrophic lateral sclerosis (SOD1-ALS) with accumulation of misfolded SOD1 proteins as intracellular inclusions in spinal motor neurons. Oligomerization of SOD1 via abnormal disulfide crosslinks has been proposed as one of the misfolding pathways occurring in mutant SOD1; however, the pathological relevance of such oligomerization in the SOD1-ALS cases still remains obscure. We prepared antibodies exclusively recognizing the SOD1 oligomers cross-linked via disulfide bonds in vitro. By using those antibodies, immunohistochemical examination and ELISA were mainly performed on the tissue samples of transgenic mice expressing mutant SOD1 proteins and also of human SOD1-ALS cases. We showed the recognition specificity of our antibodies exclusively toward the disulfide-crosslinked SOD1 oligomers by ELISA using various forms of purified SOD1 proteins in conformationally distinct states in vitro. Furthermore, the epitope of those antibodies was buried and inaccessible in the natively folded structure of SOD1. The antibodies were then found to specifically detect the pathological SOD1 species in the spinal motor neurons of the SOD1-ALS patients as well as the transgenic model mice. Our findings here suggest that the SOD1 oligomerization through the disulfide-crosslinking associates with exposure of the SOD1 structural interior and is a pathological process occurring in the SOD1-ALS cases.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D008822 Mice, Transgenic Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN. Transgenic Mice,Founder Mice, Transgenic,Mouse, Founder, Transgenic,Mouse, Transgenic,Mice, Transgenic Founder,Transgenic Founder Mice,Transgenic Mouse
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000072105 Superoxide Dismutase-1 A superoxide dismutase (SOD1) that requires copper and zinc ions for its activity to destroy SUPEROXIDE FREE RADICALS within the CYTOPLASM. Mutations in the SOD1 gene are associated with AMYOTROPHIC LATERAL SCLEROSIS-1. Cu-Zn Superoxide Dismutase,Cuprozinc Superoxide Dismutase,SOD-1 Protein,SOD1 Protein,Superoxide Dismutase 1,Cu Zn Superoxide Dismutase,SOD 1 Protein,Superoxide Dismutase, Cu-Zn,Superoxide Dismutase, Cuprozinc
D000690 Amyotrophic Lateral Sclerosis A degenerative disorder affecting upper MOTOR NEURONS in the brain and lower motor neurons in the brain stem and SPINAL CORD. Disease onset is usually after the age of 50 and the process is usually fatal within 3 to 6 years. Clinical manifestations include progressive weakness, atrophy, FASCICULATION, hyperreflexia, DYSARTHRIA, dysphagia, and eventual paralysis of respiratory function. Pathologic features include the replacement of motor neurons with fibrous ASTROCYTES and atrophy of anterior SPINAL NERVE ROOTS and corticospinal tracts. (From Adams et al., Principles of Neurology, 6th ed, pp1089-94) ALS - Amyotrophic Lateral Sclerosis,Lou Gehrig Disease,Motor Neuron Disease, Amyotrophic Lateral Sclerosis,Amyotrophic Lateral Sclerosis With Dementia,Amyotrophic Lateral Sclerosis, Guam Form,Amyotrophic Lateral Sclerosis, Parkinsonism-Dementia Complex of Guam,Amyotrophic Lateral Sclerosis-Parkinsonism-Dementia Complex 1,Charcot Disease,Dementia With Amyotrophic Lateral Sclerosis,Gehrig's Disease,Guam Disease,Guam Form of Amyotrophic Lateral Sclerosis,Lou Gehrig's Disease,Lou-Gehrigs Disease,ALS Amyotrophic Lateral Sclerosis,Amyotrophic Lateral Sclerosis Parkinsonism Dementia Complex 1,Amyotrophic Lateral Sclerosis, Parkinsonism Dementia Complex of Guam,Disease, Guam,Disease, Lou-Gehrigs,Gehrig Disease,Gehrigs Disease,Sclerosis, Amyotrophic Lateral
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015153 Blotting, Western Identification of proteins or peptides that have been electrophoretically separated by blot transferring from the electrophoresis gel to strips of nitrocellulose paper, followed by labeling with antibody probes. Immunoblotting, Western,Western Blotting,Western Immunoblotting,Blot, Western,Immunoblot, Western,Western Blot,Western Immunoblot,Blots, Western,Blottings, Western,Immunoblots, Western,Immunoblottings, Western,Western Blots,Western Blottings,Western Immunoblots,Western Immunoblottings
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

Eiichi Tokuda, and Itsuki Anzai, and Takao Nomura, and Keisuke Toichi, and Masahiko Watanabe, and Shinji Ohara, and Seiji Watanabe, and Koji Yamanaka, and Yuta Morisaki, and Hidemi Misawa, and Yoshiaki Furukawa
Pathological roles of wild-type cu, zn-superoxide dismutase in amyotrophic lateral sclerosis.
January 2012, Neurology research international,
Eiichi Tokuda, and Itsuki Anzai, and Takao Nomura, and Keisuke Toichi, and Masahiko Watanabe, and Shinji Ohara, and Seiji Watanabe, and Koji Yamanaka, and Yuta Morisaki, and Hidemi Misawa, and Yoshiaki Furukawa
Intracellular seeded aggregation of mutant Cu,Zn-superoxide dismutase associated with amyotrophic lateral sclerosis.
August 2013, FEBS letters,
Eiichi Tokuda, and Itsuki Anzai, and Takao Nomura, and Keisuke Toichi, and Masahiko Watanabe, and Shinji Ohara, and Seiji Watanabe, and Koji Yamanaka, and Yuta Morisaki, and Hidemi Misawa, and Yoshiaki Furukawa
Instability of mutant Cu/Zn superoxide dismutase (Ala4Thr) associated with familial amyotrophic lateral sclerosis.
June 1996, Neuroscience letters,
Eiichi Tokuda, and Itsuki Anzai, and Takao Nomura, and Keisuke Toichi, and Masahiko Watanabe, and Shinji Ohara, and Seiji Watanabe, and Koji Yamanaka, and Yuta Morisaki, and Hidemi Misawa, and Yoshiaki Furukawa
Expression, purification, and characterization of a familial amyotrophic lateral sclerosis-associated D90A Cu,Zn-superoxide dismutase mutant.
August 1998, Molecules and cells,
Eiichi Tokuda, and Itsuki Anzai, and Takao Nomura, and Keisuke Toichi, and Masahiko Watanabe, and Shinji Ohara, and Seiji Watanabe, and Koji Yamanaka, and Yuta Morisaki, and Hidemi Misawa, and Yoshiaki Furukawa
Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase.
August 1993, Science (New York, N.Y.),
Eiichi Tokuda, and Itsuki Anzai, and Takao Nomura, and Keisuke Toichi, and Masahiko Watanabe, and Shinji Ohara, and Seiji Watanabe, and Koji Yamanaka, and Yuta Morisaki, and Hidemi Misawa, and Yoshiaki Furukawa
A copper-deficient form of mutant Cu/Zn-superoxide dismutase as an early pathological species in amyotrophic lateral sclerosis.
June 2018, Biochimica et biophysica acta. Molecular basis of disease,
Eiichi Tokuda, and Itsuki Anzai, and Takao Nomura, and Keisuke Toichi, and Masahiko Watanabe, and Shinji Ohara, and Seiji Watanabe, and Koji Yamanaka, and Yuta Morisaki, and Hidemi Misawa, and Yoshiaki Furukawa
Folding of Cu, Zn superoxide dismutase and familial amyotrophic lateral sclerosis.
November 2003, Journal of molecular biology,
Eiichi Tokuda, and Itsuki Anzai, and Takao Nomura, and Keisuke Toichi, and Masahiko Watanabe, and Shinji Ohara, and Seiji Watanabe, and Koji Yamanaka, and Yuta Morisaki, and Hidemi Misawa, and Yoshiaki Furukawa
The metabolic hypothesis in amyotrophic lateral sclerosis: insights from mutant Cu/Zn-superoxide dismutase mice.
May 2005, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
Eiichi Tokuda, and Itsuki Anzai, and Takao Nomura, and Keisuke Toichi, and Masahiko Watanabe, and Shinji Ohara, and Seiji Watanabe, and Koji Yamanaka, and Yuta Morisaki, and Hidemi Misawa, and Yoshiaki Furukawa
Cu/Zn superoxide dismutase (SOD1) mutations and sporadic amyotrophic lateral sclerosis.
October 1993, Lancet (London, England),
Eiichi Tokuda, and Itsuki Anzai, and Takao Nomura, and Keisuke Toichi, and Masahiko Watanabe, and Shinji Ohara, and Seiji Watanabe, and Koji Yamanaka, and Yuta Morisaki, and Hidemi Misawa, and Yoshiaki Furukawa
[Familial amyotrophic lateral sclerosis associated with mutant Cu/Zn superoxide dismutase as a conformational disease].
December 1999, Rinsho shinkeigaku = Clinical neurology,
Copied contents to your clipboard!